Report of Independent Registered Public
Accounting Firm

To the Board of Trustees of SunAmerica Specialty Series
and Shareholders for each of the funds listed in the table
below

In planning and performing our audits of the financial
statements of each of the funds listed in the table below
(constituting SunAmerica Specialty Series, hereafter
referred to as the "Funds") as of and for the year ended
October 31, 2020, in accordance with the standards of
the Public Company Accounting Oversight Board
(United States) (PCAOB), we considered the Funds'
internal control over financial reporting, including
controls over safeguarding securities, as a basis for
designing our auditing procedures for the purpose of
expressing our opinion on the financial statements and
to comply with the requirements of Form N-CEN, but
not for the purpose of expressing an opinion on the
effectiveness of the Funds' internal control over financial
reporting.  Accordingly, we do not express an opinion on
the effectiveness of the Funds' internal control over
financial reporting.

SunAmerica Specialty Series
  AIG Commodity Strategy Fund
  AIG ESG Dividend Fund
  AIG Focused Alpha Large-Cap Fund
  AIG Focused Growth Fund
  AIG Income Explorer Fund
  AIG Small-Cap Fund

The management of the Funds is responsible for
establishing and maintaining effective internal control
over financial reporting.  In fulfilling this responsibility,
estimates and judgments by management are required to
assess the expected benefits and related costs of controls.
A Company's internal control over financial reporting is
a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes
in accordance with generally accepted accounting
principles.  A Company's internal control over financial
reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and
dispositions of the assets of the Company; (2) provide
reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements
in accordance with generally accepted accounting
principles, and that receipts and expenditures of the
Company are being made only in accordance with
authorizations of management and trustees of the
Company; and (3) provide reasonable assurance
regarding prevention or timely detection of unauthorized
acquisition, use or disposition of each Company's assets
that could have a material effect on the financial
statements.

Because of its inherent limitations, internal control over
financial reporting may not prevent or detect
misstatements.  Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in
conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
A deficiency in internal control over financial reporting
exists when the design or operation of a control does not
allow management or employees, in the normal course of
performing their assigned functions, to prevent or detect
misstatements on a timely basis.  A material weakness is
a deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a
reasonable possibility that a material misstatement of
the Company's annual or interim financial statements
will not be prevented or detected on a timely basis.
Our consideration of the Funds' internal control over
financial reporting was for the limited purpose described
in the first paragraph and would not necessarily disclose
all deficiencies in internal control over financial
reporting that might be material weaknesses under
standards established by the PCAOB.  However, we
noted no deficiencies in the Funds' internal control over
financial reporting and its operation, including controls
over safeguarding securities that we consider to be
material weaknesses as defined above as of October 31,
2020.
This report is intended solely for the information and use
of management and the Board of Trustees of
SunAmerica Specialty Series and the Securities and
Exchange Commission and is not intended to be and
should not be used by anyone other than these specified
parties.


/s/ PricewaterhouseCoopers LLP
Houston, Texas
December 23, 2020